A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes
Clinical trial NCT03817463 · COMPLETED
Trial details
- NCT number
- NCT03817463
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-04-15
- Primary completion
- 2021-12-10
- Enrollment
- 327624
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.